About Janssen

Janssen Pharmaceutical Companies are dedicated to addressing and solving the most important unmet medical needs of our time, including oncology (e.g. multiple myeloma and prostate cancer), immunology (e.g. psoriasis), neuroscience (e.g. schizophrenia, dementia and pain), infectious disease (e.g. HIV/AIDS, Hepatitis C and tuberculosis), and cardiovascular and metabolic diseases (e.g. diabetes).

Driven by our commitment to patients, we develop sustainable, integrated healthcare solutions that will restore and extend the quality of life.

Tibotec R&D is part of the Janssen Pharmaceutical Companies and is dedicated to the discovery and development of innovative new drugs for HIV/AIDS and other infectious diseases of high unmet medical need. More info on www.tibotec.com.

The stop-hepatatis-c website has been developed by Tibotec and Janssen as part of an ongoing commitment to improving the lives of patients through the provision of useful and relevant information about hepatitis C.